China is the bigger Cardiovascular Health Supplements market: $547 Mn against $124 Mn in 2023, about 4.4 times as large.
India grows faster: 8.7% a year, against 7.2%. The gap still grows from $423 Mn to $811 Mn by 2033.
Clinical research: 17 active trials in China, 2 in India.
| Measure |  China |  India |
|---|---|---|
| Market size, 2023 | $547 Mn | $124 Mn |
| Market size, 2033 projected | $1.1 Bn | $285 Mn |
| Growth a year (CAGR) | 7.2% | 8.7% |
| Money added, 2023–2033 | $549 Mn | $161 Mn |
| Share of the world market | 8% | 1.8% |
| Size rank of 24 countries | #2 | #12 |
| Market per person, 2023 | $0.39 | $0.08 |
| Active clinical trials | 17 | 2 |
| High blood pressure (ages 30–79) % of adults 30–79 (WHO) | 27.3 2019 | 31.1 2019 |
| Full report | China report | India report |
Year by year, 2023 to 2033
China India · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
Quick answers
Which is bigger in Cardiovascular Health Supplements, China or India?
China is the bigger Cardiovascular Health Supplements market: $547 Mn against $124 Mn in 2023, about 4.4 times as large.
Which grows faster in Cardiovascular Health Supplements, China or India?
India grows faster: 8.7% a year, against 7.2%. The gap still grows from $423 Mn to $811 Mn by 2033.
More Cardiovascular Health Supplements comparisons
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Health figures: WHO. Population: World Bank.